Boston, MA, March 15, 2022 – OrthoSpineNews
NanoHive Medical is excited to announce that the company has been selected to present at the Canaccord Genuity Musculoskeletal Conference, March 22, 2022. Patrick O’Donnell, President & CEO for NanoHive Medical, will be presenting on the company’s Hive™ portfolio of distinctly innovative 3D printed spinal interbody fusion devices as well as an overview on the company’s progress and 2022 initiatives.
A rapid growth stage company, NanoHive Medical is driving commercialization activity in the $1.9B U.S. spine interbody market segment through distribution expansion initiatives and new product introductions. The company’s Hive™ portfolio of interbody devices are designed with Soft Titanium® technology, incorporating highly innovative, patented load bearing lattice structure and independent endplates.
The conference, held prior to the American Academy of Orthopaedic Surgeons conference in Chicago, will explore the current state of orthopedics, robotic surgery, imaging/enabling technologies, biologics, and regenerative medicine companies. This event is expected to have 50 companies present, both public and private, along with a keynote presentation featuring Canaccord Genuity’s Chief Market Strategist, Tony Dwyer.
NanoHive Medical, LLC is a pioneer and leading innovator in 3D printed spinal interbody fusion implants and instrumentation. The company’s proprietary, biomimetic Soft Titanium® technology clearly distinguishes their products in the $1.9B spinal interbody fusion device market. The Hive™ portfolio of interbody fusion devices provide surgeons and their patients ideal biomechanical elastic modulus properties, clear and precise diagnostic imaging capability, osteoblast cell attraction and integration – all features that lead to consistently strong fusion constructs and efficacious clinical experiences.